Antigen-presenting cell surface molecule (generic; see below for more specifics) (APC (if considering the cell type rather than a molecule))

The **stimulation of the immune system via antigen-presenting cell membrane interaction** refers to the process through which antigen-presenting cells (APCs)—including dendritic cells, macrophages, and B cells—capture, process, and present antigens on their surface using major histocompatibility complex (MHC) molecules[3][1][2]. These antigens are recognized by T cells through their T cell receptors (TCRs), a process requiring both antigen-MHC complexes and co-stimulatory molecules (such as CD80/CD86 on APCs engaging CD28 on T cells)[5]. This interaction is crucial for activating T cells, linking innate and adaptive immunity, and orchestrating immune responses to pathogens, tumors, and vaccines[4][5][7]. Dysregulation of these interactions can lead to autoimmunity, chronic inflammation, or loss of immune tolerance.

Other names

antigen-presenting cell–T cell interactionAPC–T cell synapseAPC membrane molecule interaction

Inhibition of T cell activation by blocking co-stimulatory molecule interactions (e.g., CTLA4-Ig drugs) Immune checkpoint inhibition Enhancement of antigen presentation for vaccination or immunotherapy (e.g., dendritic cell vaccines in cancer)